Scope Fluidics (SCP) Stock Overview
A biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
SCP Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Scope Fluidics S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł145.80 |
| 52 Week High | zł197.00 |
| 52 Week Low | zł133.60 |
| Beta | -0.0078 |
| 1 Month Change | 0.97% |
| 3 Month Change | -18.46% |
| 1 Year Change | -12.17% |
| 3 Year Change | -39.00% |
| 5 Year Change | -0.82% |
| Change since IPO | 701.10% |
Recent News & Updates
Shareholder Returns
| SCP | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | 1.8% | -1.1% | -0.02% |
| 1Y | -12.2% | 2.0% | 36.8% |
Return vs Industry: SCP underperformed the Polish Medical Equipment industry which returned 1.6% over the past year.
Return vs Market: SCP underperformed the Polish Market which returned 38.8% over the past year.
Price Volatility
| SCP volatility | |
|---|---|
| SCP Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 4.9% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PL Market | 9.8% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: SCP has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: SCP's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 132 | Piotr Garstecki | www.scopefluidics.com |
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.
Scope Fluidics S.A. Fundamentals Summary
| SCP fundamental statistics | |
|---|---|
| Market cap | zł461.93m |
| Earnings (TTM) | zł54.47m |
| Revenue (TTM) | zł718.00k |
Is SCP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SCP income statement (TTM) | |
|---|---|
| Revenue | zł718.00k |
| Cost of Revenue | zł2.00m |
| Gross Profit | -zł1.28m |
| Other Expenses | -zł55.76m |
| Earnings | zł54.47m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 17.19 |
| Gross Margin | -178.69% |
| Net Profit Margin | 7,586.77% |
| Debt/Equity Ratio | 0% |
How did SCP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 15:32 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Scope Fluidics S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lukasz Kosiarski | Ipopema Securities S.A. |